Conserving Europe's Wildlife : Law And Policy of The Natura 2000 Network of Protected Areas

This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law.

This book advances a comprehensive moral defense of freedom of expression—one with implications for law and policy, but also for the choices of individuals and non-governmental institutions. Gary Chartier seeks to ground expressive freedom in mutually supportive concerns related to themes including property, autonomy, flourishing, and discovery, while seeking to tightly cabin the range of potential injuries that might trigger legal liability for expressive activity. Chartier argues suggestively for an understanding of expressive freedom as rooted and realized in a complex set of social ecosystems that merit protection on multiple grounds and applies it provocatively to a range of contemporary issues.